Please login to the form below

Not currently logged in
Email:
Password:

Elliott Levy joins Amgen from BMS

He is appointed senior VP, global development

Dr Elliott Levy has left his role at Bristol-Myers Squibb to join Amgen as senior VO, global development.

Levy was most recently senior VP and head of specialty development at BMS, where he spent 17 years.

During this time he served in a number of senior roles including head of global pharmacovigilance and epidemiology.

“Elliott brings a wealth of development and leadership experience to his new role at Amgen,” said Dr Sean Harper, executive VP of R&D at Amgen.

“His track record shows his success in leading major clinical development programmes, and we're confident that he will help Amgen to serve patients by advancing the large number of potential new medicines in our late-stage pipeline.”

26th August 2014

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
#DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
Take a look at this infographic showing some of the most notorious clinical trials and medical research in history....
Looking back at the year when everything changed
COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families....

Infographics